Breakthrough T1D ✓

@BreakthroughT1D · Headquarters in New York, NY · joined 25 Feb 2009

As we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it. We are Breakthrough T1D.

62 748Followers

1 539Following

13 773Posts total

9.8KViews on collected posts

Posts recentes

Breakthrough T1D ✓@BreakthroughT1D10 Sep

Until now, clinicians have lacked concrete guidance on who, when, and how to screen for type 1 diabetes (T1D). Led by Breakthrough T1D, experts around the globe have provided practical guidance for screening. Learn more here: https://t.co/v1z4RkXbsc https://t.co/VMSrUEi2TB

2.6K views · 14 likes · 4 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D9 Sep

If you or a loved one lives with type 1 diabetes (T1D) and has been impacted by Hurricane Lowell, visit the link below to learn more about available resources! Stay safe! 💙 https://t.co/9Np1XBKztk 1.5K views · 5 likes · 0 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D4 Sep

An exciting step forward for cell therapies! Swipe to learn the latest, and be sure to stay tuned to learn more! Want to learn more about the research we’re funding? Visit the link below! https://t.co/LhAXTQ7LYb https://t.co/WtDRc27tiL

1.6K views · 24 likes · 4 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D3 Sep

Thank you, Representatives @RepDianaDeGette, @RepMMM, @RepKimSchrier, @RepBresnahan, and @RepAngieCraig for leading the charge in the House on insulin affordability by introducing the bipartisan INSULIN Act of 2026. Insulin isn’t a choice; it’s a necessity. That’s why 1.9K views · 21 likes · 7 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D3 Sep

@BreakthroughT1D Feels like a “five years away” promise again.. 45 views · 0 likes · 0 reposts · 1 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D2 Sep

@BreakthroughT1D Will a recording or plain-language recap of the Northern California panel be shared? That would give people who couldn't attend a way to catch up on the discussion. 30 views · 1 likes · 0 reposts · 0 replies Open on X →

Breakthrough T1D ✓@BreakthroughT1D2 Sep

Clinical trials are bringing us closer to curing type 1 diabetes! Over the weekend, the Breakthrough T1D Northern California team hosted a Community Summit panel with Dr. Piotr Witkowski (University of Chicago), Dr. Gary Meininger (Sana Biotechnology), and moderator Karen https:

2.1K views · 13 likes · 2 reposts · 2 replies Open on X →

Em comparação com contas do mesmo porte

7 posts dos últimos 90 dias, ao lado da faixa de 10K–100K seguidores. bem na mediana da sua faixa de seguidores.

Mediana de visualizações1 649esta conta917mediana para 10K–100K

Alcance, %2.63%esta conta3.39%mediana para 10K–100K

Engajamento, %1.49%esta conta1.53%mediana para 10K–100K

Métrica	Esta conta	Mediana para 10K–100K	Proporção
Mediana de visualizações por post	1 649	917	1.80×
Alcance (visualizações ÷ seguidores)	2.63%	3.39%	0.78×
Taxa de engajamento	1.49%	1.53%	0.97×

Outras contas desta faixa → Comparar com outra conta → Como estas referências são construídas →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.1K2 Sep

453 Sep

1.9K

1.6K4 Sep

1.5K9 Sep

2.6K10 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.82%2 Sep

3.33%

2.22%3 Sep

1.49%

1.70%4 Sep

0.34%9 Sep

0.69%10 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.53%.

What the audience does

Likes77.2%78 in total

Reposts16.8%17 in total

Replies3.0%3 in total

Bookmarks3.0%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.